No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-05

AUTHORS

Polyzois Makras, Athanasios D. Anastasilakis, Stergios A. Polyzos, Ilias Bisbinas, Grigorios T. Sakellariou, Socrates E. Papapoulos

ABSTRACT

The acute-phase response (APR) is frequently observed in patients treated with intravenous (iv) zoledronate (ZOL). We investigated whether a short course of rosuvastatin (ROSU) could attenuate the ZOL--induced APR through blocking the mevalonate pathway at a proximal level. Twenty-eight osteoporotic postmenopausal women with no prior bisphosphonate use (mean age 65.3 ± 1.9 years) were subjected to ZOL iv infusion. Patients were randomly assigned into either a ROSU+ group (n = 12), which received ROSU 10 mg/day starting 5 days before the infusion of ZOL for a total period of 11 days, or a ROSU- group (n = 16), which did not receive ROSU. The visual analog pain scale (VAS) for musculoskeletal symptoms and body temperature was used to define clinically APR. In addition, white blood cell (WBC) count, leukocytic subpopulations, and C-reactive protein (CRP) were obtained before and 48 h following the infusion. Seven (58.3%) patients in the ROSU+ group and 13 (81.3%) in the ROSU- group experienced APR (P = not significant). No difference was found in fever and VAS measurements. CRP and granulocytes increased significantly in both groups; WBC count increased, while lymphocytes and eosinophils decreased significantly only in the ROSU- group. In a post hoc analysis of only patients with an APR, all laboratory parameters exhibited a similar significant change solely within the ROSU- group. In conclusion, our data suggest that a short course of ROS at this dose cannot prevent the ZOL-induced APR among osteoporotic women. Milder changes in acute-phase laboratory parameters in ROSU+ patients suggest that studies with higher doses may be warranted. More... »

PAGES

402-408

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00223-011-9468-2

DOI

http://dx.doi.org/10.1007/s00223-011-9468-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030597776

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21305270


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute-Phase Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Temperature", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Density Conservation Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Reactive Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diphosphonates", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorobenzenes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Imidazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukocyte Count", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Osteoporosis, Postmenopausal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pain Measurement", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rosuvastatin Calcium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Endocrinology and Diabetes, 251 Hellenic Air Force and VA General Hospital, 3 Kanellopoulou St, 115 25, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Makras", 
        "givenName": "Polyzois", 
        "id": "sg:person.01325445127.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325445127.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "424 General Military Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413162.3", 
          "name": [
            "Department of Endocrinology, 424 Military Hospital, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anastasilakis", 
        "givenName": "Athanasios D.", 
        "id": "sg:person.0665320523.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665320523.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Aristotle University of Thessaloniki", 
          "id": "https://www.grid.ac/institutes/grid.4793.9", 
          "name": [
            "Second Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Polyzos", 
        "givenName": "Stergios A.", 
        "id": "sg:person.0720405206.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720405206.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "424 General Military Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413162.3", 
          "name": [
            "First Department of Orthopaedics, 424 Military Hospital, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bisbinas", 
        "givenName": "Ilias", 
        "id": "sg:person.01336521445.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336521445.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "424 General Military Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413162.3", 
          "name": [
            "Department of Rheumatology, 424 Military Hospital, Thessaloniki, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sakellariou", 
        "givenName": "Grigorios T.", 
        "id": "sg:person.0633522243.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633522243.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Leiden University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.10419.3d", 
          "name": [
            "Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Papapoulos", 
        "givenName": "Socrates E.", 
        "id": "sg:person.055300325.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.055300325.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf02556671", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000398636", 
          "https://doi.org/10.1007/bf02556671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2008.07435.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003370920"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1359/jbmr.090819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003519718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1359/jbmr.090819", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003519718"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.1780231018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006078467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bone.2007.01.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010366460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10557-009-6181-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013522667", 
          "https://doi.org/10.1007/s10557-009-6181-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10557-009-6181-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013522667", 
          "https://doi.org/10.1007/s10557-009-6181-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10557-009-6181-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013522667", 
          "https://doi.org/10.1007/s10557-009-6181-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/bbrc.1999.1499", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015606620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2006.11.036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017330781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.295.6609.1301", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017891570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1359/jbmr.0301230", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023458599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1359/jbmr.2003.18.1.88", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027013227"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1359/jbmr.081016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034396173"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bone.2010.10.177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038782809"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-0843", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038957946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jbmr.5650100617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039187784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jbmr.5650100617", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039187784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa067312", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039913130"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002239900353", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041821502", 
          "https://doi.org/10.1007/s002239900353"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5551/jat.5652", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049463111"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1359/jbmr.1999.14.5.722", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052827500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2010-0597", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064292127"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074751743", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-05", 
    "datePublishedReg": "2011-05-01", 
    "description": "The acute-phase response (APR) is frequently observed in patients treated with intravenous (iv) zoledronate (ZOL). We investigated whether a short course of rosuvastatin (ROSU) could attenuate the ZOL--induced APR through blocking the mevalonate pathway at a proximal level. Twenty-eight osteoporotic postmenopausal women with no prior bisphosphonate use (mean age 65.3 \u00b1 1.9 years) were subjected to ZOL iv infusion. Patients were randomly assigned into either a ROSU+ group (n = 12), which received ROSU 10 mg/day starting 5 days before the infusion of ZOL for a total period of 11 days, or a ROSU- group (n = 16), which did not receive ROSU. The visual analog pain scale (VAS) for musculoskeletal symptoms and body temperature was used to define clinically APR. In addition, white blood cell (WBC) count, leukocytic subpopulations, and C-reactive protein (CRP) were obtained before and 48 h following the infusion. Seven (58.3%) patients in the ROSU+ group and 13 (81.3%) in the ROSU- group experienced APR (P = not significant). No difference was found in fever and VAS measurements. CRP and granulocytes increased significantly in both groups; WBC count increased, while lymphocytes and eosinophils decreased significantly only in the ROSU- group. In a post hoc analysis of only patients with an APR, all laboratory parameters exhibited a similar significant change solely within the ROSU- group. In conclusion, our data suggest that a short course of ROS at this dose cannot prevent the ZOL-induced APR among osteoporotic women. Milder changes in acute-phase laboratory parameters in ROSU+ patients suggest that studies with higher doses may be warranted.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00223-011-9468-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1089641", 
        "issn": [
          "0171-967X", 
          "1432-0827"
        ], 
        "name": "Calcified Tissue International", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "88"
      }
    ], 
    "name": "No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response", 
    "pagination": "402-408", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "91c38ab51bbce498b4a3ce7afb0e8ee4eb2ec879fa43e2ddda581bee4c49b230"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21305270"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7905481"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00223-011-9468-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030597776"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00223-011-9468-2", 
      "https://app.dimensions.ai/details/publication/pub.1030597776"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8663_00000489.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00223-011-9468-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00223-011-9468-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00223-011-9468-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00223-011-9468-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00223-011-9468-2'


 

This table displays all metadata directly associated to this object as RDF triples.

267 TRIPLES      21 PREDICATES      72 URIs      43 LITERALS      31 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00223-011-9468-2 schema:about N02111510ec584993826c2bc930b54bc5
2 N20760415aa1f496e93d31ed325b8c6b1
3 N221b35c0131e441aa0ac34f8f37b11cc
4 N353352c5a28e4a688bf1b387ce8d764d
5 N46e443111067416bbf48b830e723a6bd
6 N4e8075ba56f8435dacf1372aa02f8db2
7 N4e9ab8df4f9b4273b8c7507a2dbafa51
8 N5beedd22247446b69a086268616999ac
9 N68268dcbed994ad39e8e2e008c15c220
10 N685f9f4c839c4c6fa2c040ddc6dc02cb
11 N6ac210fb65fb488493964746310db34b
12 N6bddf0df582c47e5aeafcaf983d4011c
13 N75a7a6249f794e90943493a84c2d1c70
14 N770ca676ff56477fa1bfb367d502ce93
15 N787feb0b201844f281bfa0e1d2e22e0a
16 N7ab8494f4b4548ad8c0947684868d346
17 N8021e8db1c744539b67bd68fec8c2494
18 N8736beb01a5347169442df7395393822
19 N92067732acfa4a0fbe027fcff25bf70a
20 Nb83ac7b155d64db8a68f9776aecf279f
21 Ndde4ab98b6ad4398a14c74f66e8f32d2
22 Nef073ac61f0c43f997feeed17eb92aff
23 anzsrc-for:11
24 anzsrc-for:1103
25 schema:author N2e8558ae964e4f33822761235f882231
26 schema:citation sg:pub.10.1007/bf02556671
27 sg:pub.10.1007/s002239900353
28 sg:pub.10.1007/s10557-009-6181-8
29 https://app.dimensions.ai/details/publication/pub.1074751743
30 https://doi.org/10.1002/art.1780231018
31 https://doi.org/10.1002/jbmr.5650100617
32 https://doi.org/10.1006/bbrc.1999.1499
33 https://doi.org/10.1016/j.amjcard.2006.11.036
34 https://doi.org/10.1016/j.bone.2007.01.016
35 https://doi.org/10.1016/j.bone.2010.10.177
36 https://doi.org/10.1056/nejmoa067312
37 https://doi.org/10.1111/j.1365-2141.2008.07435.x
38 https://doi.org/10.1136/bmj.295.6609.1301
39 https://doi.org/10.1158/1078-0432.ccr-06-0843
40 https://doi.org/10.1210/jc.2010-0597
41 https://doi.org/10.1359/jbmr.0301230
42 https://doi.org/10.1359/jbmr.081016
43 https://doi.org/10.1359/jbmr.090819
44 https://doi.org/10.1359/jbmr.1999.14.5.722
45 https://doi.org/10.1359/jbmr.2003.18.1.88
46 https://doi.org/10.5551/jat.5652
47 schema:datePublished 2011-05
48 schema:datePublishedReg 2011-05-01
49 schema:description The acute-phase response (APR) is frequently observed in patients treated with intravenous (iv) zoledronate (ZOL). We investigated whether a short course of rosuvastatin (ROSU) could attenuate the ZOL--induced APR through blocking the mevalonate pathway at a proximal level. Twenty-eight osteoporotic postmenopausal women with no prior bisphosphonate use (mean age 65.3 ± 1.9 years) were subjected to ZOL iv infusion. Patients were randomly assigned into either a ROSU+ group (n = 12), which received ROSU 10 mg/day starting 5 days before the infusion of ZOL for a total period of 11 days, or a ROSU- group (n = 16), which did not receive ROSU. The visual analog pain scale (VAS) for musculoskeletal symptoms and body temperature was used to define clinically APR. In addition, white blood cell (WBC) count, leukocytic subpopulations, and C-reactive protein (CRP) were obtained before and 48 h following the infusion. Seven (58.3%) patients in the ROSU+ group and 13 (81.3%) in the ROSU- group experienced APR (P = not significant). No difference was found in fever and VAS measurements. CRP and granulocytes increased significantly in both groups; WBC count increased, while lymphocytes and eosinophils decreased significantly only in the ROSU- group. In a post hoc analysis of only patients with an APR, all laboratory parameters exhibited a similar significant change solely within the ROSU- group. In conclusion, our data suggest that a short course of ROS at this dose cannot prevent the ZOL-induced APR among osteoporotic women. Milder changes in acute-phase laboratory parameters in ROSU+ patients suggest that studies with higher doses may be warranted.
50 schema:genre research_article
51 schema:inLanguage en
52 schema:isAccessibleForFree false
53 schema:isPartOf N59b638bfcfda4f4c8e1d86dba7e2a7e2
54 Nf7a6f317d838430ca6fa5dcd6cdf5178
55 sg:journal.1089641
56 schema:name No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response
57 schema:pagination 402-408
58 schema:productId N0add777885884ed5bca65e933d895535
59 N11043f35b8084dfa955762f431df52f6
60 N35e8bcec83d24cd1a5435217d2b82f43
61 N39c1e6a0b11e429cba1d5b6f357558c4
62 Ne329771f57d04977bd6552bd48ecde5e
63 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030597776
64 https://doi.org/10.1007/s00223-011-9468-2
65 schema:sdDatePublished 2019-04-10T14:55
66 schema:sdLicense https://scigraph.springernature.com/explorer/license/
67 schema:sdPublisher N746a6fdd96c1468fb73433f824f5ea15
68 schema:url http://link.springer.com/10.1007/s00223-011-9468-2
69 sgo:license sg:explorer/license/
70 sgo:sdDataset articles
71 rdf:type schema:ScholarlyArticle
72 N02111510ec584993826c2bc930b54bc5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Female
74 rdf:type schema:DefinedTerm
75 N0add777885884ed5bca65e933d895535 schema:name doi
76 schema:value 10.1007/s00223-011-9468-2
77 rdf:type schema:PropertyValue
78 N11043f35b8084dfa955762f431df52f6 schema:name nlm_unique_id
79 schema:value 7905481
80 rdf:type schema:PropertyValue
81 N1a8ea9afafd249c495f3490e94a59277 rdf:first sg:person.0665320523.06
82 rdf:rest Nd887393e6ae243ce9b84f6a63635200f
83 N20760415aa1f496e93d31ed325b8c6b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Treatment Outcome
85 rdf:type schema:DefinedTerm
86 N221b35c0131e441aa0ac34f8f37b11cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Bone Density Conservation Agents
88 rdf:type schema:DefinedTerm
89 N2e8558ae964e4f33822761235f882231 rdf:first sg:person.01325445127.11
90 rdf:rest N1a8ea9afafd249c495f3490e94a59277
91 N353352c5a28e4a688bf1b387ce8d764d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Imidazoles
93 rdf:type schema:DefinedTerm
94 N35e8bcec83d24cd1a5435217d2b82f43 schema:name dimensions_id
95 schema:value pub.1030597776
96 rdf:type schema:PropertyValue
97 N39c1e6a0b11e429cba1d5b6f357558c4 schema:name pubmed_id
98 schema:value 21305270
99 rdf:type schema:PropertyValue
100 N46e443111067416bbf48b830e723a6bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name C-Reactive Protein
102 rdf:type schema:DefinedTerm
103 N4e8075ba56f8435dacf1372aa02f8db2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Osteoporosis, Postmenopausal
105 rdf:type schema:DefinedTerm
106 N4e9ab8df4f9b4273b8c7507a2dbafa51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Rosuvastatin Calcium
108 rdf:type schema:DefinedTerm
109 N59b638bfcfda4f4c8e1d86dba7e2a7e2 schema:volumeNumber 88
110 rdf:type schema:PublicationVolume
111 N5beedd22247446b69a086268616999ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Pyrimidines
113 rdf:type schema:DefinedTerm
114 N68268dcbed994ad39e8e2e008c15c220 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Fluorobenzenes
116 rdf:type schema:DefinedTerm
117 N685f9f4c839c4c6fa2c040ddc6dc02cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N6ac210fb65fb488493964746310db34b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Sulfonamides
122 rdf:type schema:DefinedTerm
123 N6bddf0df582c47e5aeafcaf983d4011c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Diphosphonates
125 rdf:type schema:DefinedTerm
126 N746a6fdd96c1468fb73433f824f5ea15 schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 N75a7a6249f794e90943493a84c2d1c70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Aged
130 rdf:type schema:DefinedTerm
131 N770ca676ff56477fa1bfb367d502ce93 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Acute-Phase Reaction
133 rdf:type schema:DefinedTerm
134 N787feb0b201844f281bfa0e1d2e22e0a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Pain Measurement
136 rdf:type schema:DefinedTerm
137 N7ab8494f4b4548ad8c0947684868d346 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Prospective Studies
139 rdf:type schema:DefinedTerm
140 N8021e8db1c744539b67bd68fec8c2494 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
142 rdf:type schema:DefinedTerm
143 N8736beb01a5347169442df7395393822 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Body Temperature
145 rdf:type schema:DefinedTerm
146 N92067732acfa4a0fbe027fcff25bf70a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Leukocyte Count
148 rdf:type schema:DefinedTerm
149 N92a6cc4f04674e438f110d6c1c15d9a7 rdf:first sg:person.055300325.70
150 rdf:rest rdf:nil
151 N9cda359a1bef4c25b76cde701182d2ff rdf:first sg:person.01336521445.86
152 rdf:rest Nee5d6ea92d5f43d48c342091bfe7063e
153 Nb83ac7b155d64db8a68f9776aecf279f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Dose-Response Relationship, Drug
155 rdf:type schema:DefinedTerm
156 Nd887393e6ae243ce9b84f6a63635200f rdf:first sg:person.0720405206.87
157 rdf:rest N9cda359a1bef4c25b76cde701182d2ff
158 Ndde4ab98b6ad4398a14c74f66e8f32d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Severity of Illness Index
160 rdf:type schema:DefinedTerm
161 Ne329771f57d04977bd6552bd48ecde5e schema:name readcube_id
162 schema:value 91c38ab51bbce498b4a3ce7afb0e8ee4eb2ec879fa43e2ddda581bee4c49b230
163 rdf:type schema:PropertyValue
164 Nee5d6ea92d5f43d48c342091bfe7063e rdf:first sg:person.0633522243.98
165 rdf:rest N92a6cc4f04674e438f110d6c1c15d9a7
166 Nef073ac61f0c43f997feeed17eb92aff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Middle Aged
168 rdf:type schema:DefinedTerm
169 Nf340c8a1f48d43609e16bb54f77519f8 schema:name Department of Endocrinology and Diabetes, 251 Hellenic Air Force and VA General Hospital, 3 Kanellopoulou St, 115 25, Athens, Greece
170 rdf:type schema:Organization
171 Nf7a6f317d838430ca6fa5dcd6cdf5178 schema:issueNumber 5
172 rdf:type schema:PublicationIssue
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
177 schema:name Clinical Sciences
178 rdf:type schema:DefinedTerm
179 sg:journal.1089641 schema:issn 0171-967X
180 1432-0827
181 schema:name Calcified Tissue International
182 rdf:type schema:Periodical
183 sg:person.01325445127.11 schema:affiliation Nf340c8a1f48d43609e16bb54f77519f8
184 schema:familyName Makras
185 schema:givenName Polyzois
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01325445127.11
187 rdf:type schema:Person
188 sg:person.01336521445.86 schema:affiliation https://www.grid.ac/institutes/grid.413162.3
189 schema:familyName Bisbinas
190 schema:givenName Ilias
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336521445.86
192 rdf:type schema:Person
193 sg:person.055300325.70 schema:affiliation https://www.grid.ac/institutes/grid.10419.3d
194 schema:familyName Papapoulos
195 schema:givenName Socrates E.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.055300325.70
197 rdf:type schema:Person
198 sg:person.0633522243.98 schema:affiliation https://www.grid.ac/institutes/grid.413162.3
199 schema:familyName Sakellariou
200 schema:givenName Grigorios T.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633522243.98
202 rdf:type schema:Person
203 sg:person.0665320523.06 schema:affiliation https://www.grid.ac/institutes/grid.413162.3
204 schema:familyName Anastasilakis
205 schema:givenName Athanasios D.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665320523.06
207 rdf:type schema:Person
208 sg:person.0720405206.87 schema:affiliation https://www.grid.ac/institutes/grid.4793.9
209 schema:familyName Polyzos
210 schema:givenName Stergios A.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720405206.87
212 rdf:type schema:Person
213 sg:pub.10.1007/bf02556671 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000398636
214 https://doi.org/10.1007/bf02556671
215 rdf:type schema:CreativeWork
216 sg:pub.10.1007/s002239900353 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041821502
217 https://doi.org/10.1007/s002239900353
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/s10557-009-6181-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013522667
220 https://doi.org/10.1007/s10557-009-6181-8
221 rdf:type schema:CreativeWork
222 https://app.dimensions.ai/details/publication/pub.1074751743 schema:CreativeWork
223 https://doi.org/10.1002/art.1780231018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006078467
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1002/jbmr.5650100617 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039187784
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1006/bbrc.1999.1499 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015606620
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/j.amjcard.2006.11.036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017330781
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.bone.2007.01.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010366460
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.bone.2010.10.177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038782809
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1056/nejmoa067312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039913130
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1111/j.1365-2141.2008.07435.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003370920
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1136/bmj.295.6609.1301 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017891570
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1158/1078-0432.ccr-06-0843 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038957946
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1210/jc.2010-0597 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064292127
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1359/jbmr.0301230 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023458599
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1359/jbmr.081016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034396173
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1359/jbmr.090819 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003519718
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1359/jbmr.1999.14.5.722 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052827500
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1359/jbmr.2003.18.1.88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027013227
254 rdf:type schema:CreativeWork
255 https://doi.org/10.5551/jat.5652 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049463111
256 rdf:type schema:CreativeWork
257 https://www.grid.ac/institutes/grid.10419.3d schema:alternateName Leiden University Medical Center
258 schema:name Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands
259 rdf:type schema:Organization
260 https://www.grid.ac/institutes/grid.413162.3 schema:alternateName 424 General Military Hospital
261 schema:name Department of Endocrinology, 424 Military Hospital, Thessaloniki, Greece
262 Department of Rheumatology, 424 Military Hospital, Thessaloniki, Greece
263 First Department of Orthopaedics, 424 Military Hospital, Thessaloniki, Greece
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.4793.9 schema:alternateName Aristotle University of Thessaloniki
266 schema:name Second Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
267 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...